Multicenter Phase II Trial of Oxaliplatin and Docetaxel for Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck.
Phase of Trial: Phase II
Latest Information Update: 04 Nov 2013
At a glance
- Drugs Docetaxel; Oxaliplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- 10 Aug 2011 Planned End Date changed from 1 Dec 2010 to 1 Nov 2009 as reported by ClinicalTrials.gov.
- 20 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 01 Jul 2009 Planned end date changed from 1 Mar 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov,